Quintiles Transitional Holdings Inc. (NYSE:Q) was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday.

A number of other brokerages have also weighed in on Q. Barclays PLC reaffirmed an “overweight” rating and issued a $98.00 price target (up from $90.00) on shares of Quintiles Transitional Holdings in a research note on Monday, July 17th. William Blair raised shares of Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $70.10 to $93.42 in a research note on Friday, August 4th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $94.00 price target on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. Citigroup Inc. upped their price target on shares of Quintiles Transitional Holdings from $96.00 to $97.00 and gave the stock a “neutral” rating in a research note on Monday, August 7th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $92.00 price target (up from $87.00) on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Quintiles Transitional Holdings has a consensus rating of “Buy” and an average price target of $90.25.

Quintiles Transitional Holdings (NYSE:Q) opened at 91.55 on Friday. The company’s 50-day moving average is $90.20 and its 200 day moving average is $84.07. The stock has a market capitalization of $19.82 billion, a PE ratio of 265.36 and a beta of 0.64. Quintiles Transitional Holdings has a 12-month low of $70.10 and a 12-month high of $93.53.

Quintiles Transitional Holdings (NYSE:Q) last posted its earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. The firm had revenue of $1.97 billion during the quarter, compared to analyst estimates of $1.96 billion. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. Quintiles Transitional Holdings’s revenue was up 68.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.93 EPS. On average, analysts predict that Quintiles Transitional Holdings will post $4.58 EPS for the current year.

Quintiles Transitional Holdings announced that its board has approved a share repurchase program on Wednesday, May 24th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the medical research company to purchase up to 5.4% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: “Quintiles Transitional Holdings Inc. (Q) Rating Increased to Strong-Buy at BidaskClub” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/21/quintiles-transitional-holdings-inc-q-rating-increased-to-strong-buy-at-bidaskclub.html.

In other news, insider Kevin C. Knightly sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the sale, the insider now owns 46,826 shares in the company, valued at $4,227,451.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Ari Bousbib sold 92,160 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the sale, the insider now owns 1,082,919 shares in the company, valued at approximately $97,841,731.65. The disclosure for this sale can be found here. Insiders sold a total of 8,864,468 shares of company stock worth $745,413,651 over the last quarter. Insiders own 6.40% of the company’s stock.

Several large investors have recently added to or reduced their stakes in Q. Vanguard Group Inc. raised its stake in Quintiles Transitional Holdings by 2.2% in the second quarter. Vanguard Group Inc. now owns 12,789,723 shares of the medical research company’s stock worth $1,144,680,000 after buying an additional 280,893 shares in the last quarter. Glenview Capital Management LLC increased its position in shares of Quintiles Transitional Holdings by 29.3% in the second quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock worth $798,461,000 after buying an additional 2,023,719 shares during the last quarter. Longview Partners Guernsey LTD increased its position in shares of Quintiles Transitional Holdings by 6.2% in the second quarter. Longview Partners Guernsey LTD now owns 8,711,447 shares of the medical research company’s stock worth $779,675,000 after buying an additional 505,526 shares during the last quarter. Janus Capital Management LLC increased its position in shares of Quintiles Transitional Holdings by 0.4% in the first quarter. Janus Capital Management LLC now owns 7,783,546 shares of the medical research company’s stock worth $626,804,000 after buying an additional 27,675 shares during the last quarter. Finally, BlackRock Inc. increased its position in shares of Quintiles Transitional Holdings by 4,217.1% in the first quarter. BlackRock Inc. now owns 7,098,723 shares of the medical research company’s stock worth $571,660,000 after buying an additional 6,934,290 shares during the last quarter. Institutional investors and hedge funds own 91.79% of the company’s stock.

About Quintiles Transitional Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Stock Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related stocks with our FREE daily email newsletter.